Young Peoples and Human Rights Ghana

http://www.plusnews.org/report.aspx?ReportID=93226 Photo: IRIN HIV-negative participants taking tenofovir had an average of 62 percent fewer HIV infections than those taking the placebo NAIROBI, 14 July 2011 (PlusNews) - A new study has added to growing evidence that a daily dose of antiretroviral treatment taken by the HIV-negative partner in a heterosexual, HIV-discordant relationship can significantly reduce the risk of HIV transmission.  The Partners PrEP trial, the largest to date to consider the effectiveness of pre-exposure prophylaxis (PrEP) for HIV prevention, involved 4,758 HIV-negative people in Kenya and Uganda, all with HIV-positive partners. One-third of HIV-negative participants took a daily tablet of the antiretroviral, tenofovir; one-third a combination of tenofovir and emtricitabine; and the rest a placebo. The trial, begun in July 2008 and conducted by the University of Washington's International Clinical Research Centre, ended a year early due to the overwhe

Subject: [LGBTI_health_africa] HIV/AIDS: Survey reveals gaps in HIV programming for MSM http://www.plusnews.org/report.aspx?ReportID=93230 Photo: Flickr Creative Commons/Spec-ta-cles Just 36 percent of MSM surveyed reported having easy access to HIV treatment NAIROBI, 14 July 2011 (PlusNews) - A new global survey of more than 5,000 men who have sex with men (MSM) reveals a marginalized group of people with little access to basic HIV prevention tools such as condoms and few means to learn about HIV.  Conducted by the Global Forum on MSM & HIV between 24 June and 17 August 2010, the survey sought to highlight key gaps in global efforts to provide MSM with evidence-informed HIV prevention services. More than 1,000 of the study participants - drawn from all over the world - were health workers; 22 percent reported being HIV-positive.  The authors recommend expanding access to HIV prevention services for MSM across the globe, more focus on promoting awareness of emerging HIV preven